167 related articles for article (PubMed ID: 35421766)
21. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells.
Liang L; Yang Y; Liu H; Yuan F; Yuan Y; Li W; Huang C; Chen J; Liu Y
J Biol Inorg Chem; 2023 Jun; 28(4):421-437. PubMed ID: 37097484
[TBL] [Abstract][Full Text] [Related]
22. Anticancer effect evaluation of iridium(III) complexes targeting mitochondria and endoplasmic reticulum.
Wang Y; Li Y; Chen J; Liu H; Zhou Y; Huang C; Liang L; Liu Y; Wang X
J Inorg Biochem; 2023 Jan; 238():112054. PubMed ID: 36335745
[TBL] [Abstract][Full Text] [Related]
23. Anticancer mechanism studies of iridium(III) complexes inhibiting osteosarcoma HOS cells proliferation.
Xie FL; Wang Y; Zhu JW; Xu HH; Guo QF; Wu Y; Liu SH
J Inorg Biochem; 2022 Dec; 237():112011. PubMed ID: 36252336
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization and irradiation enhances anticancer activity of liposome-loaded iridium(III) complexes.
Tian S; Nie Q; Chen H; Liang L; Hu H; Tang S; Yang J; Liu Y; Yin H
J Inorg Biochem; 2024 Jul; 256():112549. PubMed ID: 38579631
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity studies of iridium (III) polypyridine complexes-loaded liposomes against gastric tumor cell in vitro.
Xie FL; Huang ZT; Bai L; Zhu JW; Xu HH; Long QQ; Guo QF; Wu Y; Liu SH
J Inorg Biochem; 2021 Dec; 225():111603. PubMed ID: 34564032
[TBL] [Abstract][Full Text] [Related]
26. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT
J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria.
Hao J; Zhang H; Tian L; Yang L; Zhou Y; Zhang Y; Liu Y; Xing D
J Inorg Biochem; 2021 Aug; 221():111465. PubMed ID: 33989986
[TBL] [Abstract][Full Text] [Related]
29. Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo.
Bai L; Fei WD; Gu YY; He M; Du F; Zhang WY; Yang LL; Liu YJ
J Inorg Biochem; 2020 Apr; 205():111014. PubMed ID: 32044395
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of iridium(III) complexes as potential antitumor agents.
Du F; Bai L; He M; Zhang WY; Gu YY; Yin H; Liu YJ
J Inorg Biochem; 2019 Dec; 201():110822. PubMed ID: 31536949
[TBL] [Abstract][Full Text] [Related]
31. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
[TBL] [Abstract][Full Text] [Related]
32. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
33. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
[TBL] [Abstract][Full Text] [Related]
34. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and antitumor mechanism investigation of iridium(III) complexes conjugated with ibuprofen.
Chen SQ; Lu XY; Zhu LY; Zhu H; Li RT; Ye RR
J Inorg Biochem; 2024 Aug; 257():112596. PubMed ID: 38759264
[TBL] [Abstract][Full Text] [Related]
36. Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents.
Chen J; Guo X; Li D; Tang H; Gao J; Yu W; Zhu X; Sun Z; Huang Z; Chen L
Metallomics; 2023 Jun; 15(6):. PubMed ID: 37204038
[TBL] [Abstract][Full Text] [Related]
37. Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor.
Yang Y; Gao Y; Sun Y; Zhao J; Gou S
J Med Chem; 2023 Oct; 66(19):13731-13745. PubMed ID: 37788351
[TBL] [Abstract][Full Text] [Related]
38. Exploring anticancer efficiency of mitochondria-targeted cyclometalated iridium(III) complexes.
Gu Y; Wen H; Bai L; Zhou Y; Zhang H; Tian L; Zhang Y; Hao J; Liu Y
J Inorg Biochem; 2020 Nov; 212():111215. PubMed ID: 32919250
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and evaluation of phosphorescent Ir(III) complexes with anticancer activity.
Liu Z; Li J; Ge X; Zhang S; Xu Z; Gao W
J Inorg Biochem; 2019 Aug; 197():110703. PubMed ID: 31077890
[TBL] [Abstract][Full Text] [Related]
40. Iridium(III) complexes conjugated with naproxen exhibit potent anti-tumor activities by inducing mitochondrial damage, modulating inflammation, and enhancing immunity.
Xie K; Lu XY; Zhu H; Zhu LY; Li RT; Ye RR
Dalton Trans; 2024 May; 53(20):8772-8780. PubMed ID: 38712840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
